The latest price target for Applied Therapeutics (NASDAQ:APLT) was reported by Leerink Partners on December 3, 2025. The analyst firm set a price target for $1.00 expecting APLT to rise to within 12 months (a possible 854.20% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Applied Therapeutics (NASDAQ:APLT) was provided by Leerink Partners, and Applied Therapeutics downgraded their market perform rating.

There is no last upgrade for Applied Therapeutics

The last downgrade for Applied Therapeutics Inc happened on December 3, 2025 when Leerink Partners changed their price target from $2 to $1 for Applied Therapeutics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied Therapeutics was filed on December 3, 2025 so you should expect the next rating to be made available sometime around December 3, 2026.

While ratings are subjective and will change, the latest Applied Therapeutics (APLT) rating was a downgraded with a price target of $2.00 to $1.00. The current price Applied Therapeutics (APLT) is trading at is $0.10, which is out of the analyst’s predicted range.